Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 27: AMD V

09:00 - 10:30 | 23 September | Room: Room C4.

Back to Previous

12:00Efficacy of novel small moleculebased NLRP3 inhibitors in retinal pigment epithelial cells
L. Wang Germany
12:06Surgical management of acute submacular hemorrhage (ASH) due to wet age related macular degeneration (wAMD): A direct comparison between three surgical methods: Pneumatic displacement with or without vitrectomy in combination with subretinal or intr
C. Skevas Germany
12:12A retrospective pilot study assessing the vessel density in nAMD after longterm antiVEGF treatment and compared to recently started antiVEGF treatment
C. Turksever Switzerland
12:18Omega3 and Vitamin D blood serum dosage in a population with moderate to high risk of AMD determined by S.T.A.R.S questionnaire
A. Leys Belgium
12:24Longterm safety and real life efficacy outcomes after combined stereotactic radiotherapy and treatandextend antiVEGF treatment for neovascular AMD
K. Hatz Switzerland
12:30Clinical characteristics and outcome in chronic central serous chorioretinopathy with focal versus extensive abnormalities
T. van Rijssen Netherlands
12:36Ranibizumab in pigment epithelial tears secondary to agerelated macular degeneration; a prospective study (the RIP Study)
T. Krohne Germany
12:42Effectiveness and safety of repeated ranibizumab 0.5 mg injections in Taiwanese patients newly diagnosed with neovascular age-related macular degeneration: 12-month real-life outcomes from the RACER study
W. C. Wu Taiwan
12:48Inflammaging in polypoidal choroidal vasculopathy and neovascular agerelated macular degeneration
Y. Subhi Denmark
12:54Longterm progression of naïve quiescent choroidal neovascularization in intermediate agerelated macular degeneration, by multimodal imaging and optical coherence tomography angiography
R. Serra Italy
13:00CD93 is a potential new target for CNV treatment
G. Neri Italy
13:06Longitudinal analysis and prognostic value of outer retinal layer intensities by SDOCT in eyes with agerelated macular degeneration
S. Thiele Germany
13:12Registry of AMD In Turkish population (REGAIN): Patient demographics and treatment approaches in neovascular age related macular degeneration (nAMD)
B. Eldem Turkey
13:18A comparison of the anatomical efficacy of brolucizumab and aflibercept in neovascular agerelated macular degeneration (nAMD): an analysis of Weeks 12–16 in the HAWK and HARRIER studies
R. Hamilton United Kingdom
Back to Previous

Sign up to EURETINA


© EURETINA All rights reserved
Loading please wait